HKU Scholars Hub: Browsing DSpace

Browsing by Author rp01466

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 297 next >

Title	Author(s)	Issue Date	Views
11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan Criteria: surgeon's perspective Journal:The Journal of Nuclear Medicine	Cheung, TT Ho, CL Lo, CM Chen, S Chan, SC Chok, KSH Fung, JYY Chan, ACY Sharr, WW Yau, TCC Poon, RTP Fan, ST	2013	120
3nd International Conference on Phase 1 and Early Phase Clinical Trials (ICPOEP 2016)	Yau, TCC	2016	98
45 Years Old Gentleman with Pancreatic Neuroendocrine Tumour: Advances in the Therapeutic Options Proceeding/Conference:Asia-Pacific Gastroenterology Cancer Summit 2013	Yau, TCC	2013
A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients Journal:Investigational New Drugs	Yau, TCC Cheng, PNM Chiu, WYJ Kwok, GW Leung, RCY Liu, AM Cheung, TT Ng, CT	2021	17
A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma Journal:Clinical Cancer Research	Yau, TCC Lencioni, R Sukeepaisarnjaroen, W Chao, Y Yen, CJ Lausoontornsiri, W Chen, PJ Sanpajit, T Camp, A Cox, DS Gagnon, R Liu, Y Raffensperger, KE Kulkarni, D Kallender, H Ottesen, LH Poon, RTP Bottaro, DP	2017	111
A phase II study of neoadjuvant chemotherapy using combined taxane, anthracycline, and cyclophosphamide in high risk HER2-negative locally advanced breast cancer Proceeding/Conference:GBCC / IBCS 2015	Chiu, WYJ Leung, RCY Suen, TKD Chen, THC Chow, CYL Kwok, G Wong, H Cheung, P Yau, TCC Kwong, A	2015	80
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma Journal:Therapeutic Advances in Medical Oncology	Qin, S Chan, SL Sukeepaisarnjaroen, W Han, G Choo, SP Sriuranpong, V Pan, H Yau, T Guo, Y Chen, M Ren, Z Xu, J Yen, CJ Lin, ZZ Manenti, L Gu, Y Sun, Y Tiedt, R Hao, L Song, W Tanwandee, T	2019	80
A preclinical study on the combination therapy of everolimus and transarterial chemoembolization in hepatocellular carcinoma Journal:American Journal of Cancer Research	Chow, KM Yau, TCC Ng, L Chu, AC Law, WL Poon, RTP Pang, RWC	2015	40
Acute presentation of rheumatoid arthritis following cancer chemotherapy using the topoisomerase I inhibitor irinotecan [3] Journal:Acta Oncologica	Yau, TC Chu, KW Mok, MY Liang, RH Epstein, RJ	2005	128
Advanced Pancreatic Cancer: Flourishing Novel Approaches in the Era of Biological Therapy Journal:Oncologist	Chiu, JWY Wong, HYH Leung, RCY Pang, RWC Cheung, TT Fan, ST Poon, RTP Yau, TCC	2014
Advances in immunotherapy in liver and gastric cancer Proceeding/Conference:Multi-specialty Medical Mega Conference, Hong Kong	Yau, TCC	2020	13
Advances in the Management of Advanced Pancreatic Cancer Proceeding/Conference:Invited Lecture, Zhejiang University International Hospital, Hangzhou, China	Yau, TCC	2017	6
Advances in the Management of Hepatocellular Carcinoma Proceeding/Conference:International Oncology Summit, Hangzhou, China	Yau, TCC	2015	13
Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy Journal:Anti-Cancer Agents in Medicinal Chemistry	Leung, R Lang, B Wong, H Chiu, J Wan, KY Shek, T Woo, YC Lo, CY Yau, T	2012	102
ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240 Journal:Therapeutic Advances in Medical Oncology	Vogel, A Merle, P Verslype, C Finn, RS Zhu, AX Cheng, AL Chan, SL Yau, T Ryoo, BY Knox, J Daniele, B Qin, S Wei, Z Miteva, Y Malhotra, U Siegel, AB Kudo, M	2021
An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma Journal:The Oncologist	El Dika, I Lim, HY Yong, WP Lin, CC Yoon, JH Modiano, M Freilich, B Choi, HJ Chao, TY Kelley, RK Brown, J Knox, J Ryoo, BY Yau, TCC Abou-Alfa, GK	2019	34
An overview in management of hepatocellular carcinoma in Hong Kong using the Hong Kong Liver Cancer (HKLC) staging system Journal:Global Health & Medicine	Chui, AMN Yau, TCC Cheung, TT	2020	6
Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour Journal:ANZ Journal of Surgery	Cheung, TT Chok, KSH Chan, ACY Yau, TCC Chan, SC Poon, RTP Fan, ST Lo, CM	2014	74
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens Journal:Breast Cancer Research and Treatment	Dai, MS Feng, YH Chen, SW Masuda, N Yau, T Chen, ST Lu, YS Yap, YS Ang, PCS Chu, SC Kwong, A Lee, KS Ow, S Kim, SB Lin, J Chung, HC Ngan, R Kok, VC Rau, KM Sangai, T Ng, TY Tseng, LM Bryce, R Bebchuk, J Chen, MC Hou, MF	2021	38
Androgen deprivation therapy and cardiovascular risk in chinese patients with nonmetastatic carcinoma of prostate. Journal:Journal of Oncology	Huang, G Yeung, CY Lee, KK LIU, J Ho, KL YIU, MK Lam, KSL Tse, HF Yau, TCC Siu, DCW	2014	96

Showing results 1 to 20 of 297 next >